NCT01536522
Asthma Inflammation Research
Enrolling by Invitation
EARLY_PHASE1Ages 18–75InterventionalThe Cleveland ClinicInvestigator-initiated
~60 participants
Updated 2026-05-28 on ClinicalTrials.gov
What's tested:Nutritional approach for asthmaLow Caloric Shakewhole lung allergen challenge
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Maintaining a tolerance to Medium Chain Triglyceride (MCT) additive for Asthmatics
Measured over 24 weeks
Conditions
Where it's being run
1 sites across 1 statesOhio1
Study leadership
- Serpil Erzurum, MD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Asthma diagnosed by a medical specialist and/or history of positive methacholine rest and/or reversibility of \>10% of FEV1
FEV1 is within acceptable limits
Informed Consent is present
Exclusion
Diabetes (fasting blood sugar \>110 mg/dL)
Any milk allergies
Coconut allergies
BMI \>40 kg/m2,
Inability to maintain diet intervention
Current smoking or smoking history of greater than 10 pack-years
Any other significant respiratory or cardiac disease or the presence of clinically important comorbidities, including, uncontrolled coronary artery disease, acute or and chronic renal failure
What this trial measures
- Maintaining a tolerance to Medium Chain Triglyceride (MCT) additive for Asthmatics24 weeks
Tolerability of the MCT will be assessed by maintenance of use of MCT by 20% or more participants over the 3 months of the study.